miR-16与miR-125b通过调控空肠claudin-2和cingulin表达参与腹泻型肠易激综合征屏障功能失调
该研究比较腹泻型肠易激综合征(IBS-D)患者与健康对照的小肠黏膜miRNA和mRNA表达谱,发现IBS-D存在独特的miRNA与mRNA表达模式,紧密连接信号与IBS-D转录谱相关。hsa-miR-125b-5p和hsa-miR-16分别调控CGN(cingulin)和CLDN2(claudin-2)表达,IBS-D中CGN和CLDN2蛋白表达上调而相应靶向miRNA下调。
要点
- IBS-D患者空肠黏膜miRNA和mRNA表达谱与健康对照存在差异,紧密连接信号与IBS-D转录谱相关。
- hsa-miR-125b-5p调控CGN、hsa-miR-16调控CLDN2,IBS-D中两蛋白表达上调而对应miRNA下调。
- 肠道功能障碍、感知压力、抑郁及肥大细胞数量与上述miRNA及其靶蛋白表达相关。
核心结论
- IBS-D中肠道上皮屏障功能调控涉及转录和转录后机制,miRNA作为主调控因子控制紧密连接蛋白表达并与主要临床症状相关。
研究设计与样本
- 纳入符合Rome III IBS-D标准的患者与健康对照,分析肠道组织样本:miRNA-mRNA表达谱分析、miRNA-mRNA配对共表达分析、通路分析与上游调控因子鉴定、miRNA与靶mRNA验证,并在肠上皮细胞中对候选miRNA-mRNA对进行功能评估。
主要发现
- IBS-D样本显示与健康对照不同的miRNA和mRNA表达谱,紧密连接信号与IBS-D转录谱相关。
- 所选基因进一步验证显示,参与上皮屏障功能的基因中75%呈一致性上调。
- 生物信息学分析确定hsa-miR-125b-5p和hsa-miR-16分别调控紧密连接基因CGN(cingulin)和CLDN2(claudin-2)的表达。
- IBS-D中CGN和CLDN2蛋白表达上调,而各自靶向miRNA下调;肠道功能障碍、感知压力、抑郁及肥大细胞数量与hsa-miR-125b-5p、hsa-miR-16及其靶蛋白表达相关。
关键数值与推荐
- IBS-D患者符合Rome III标准;参与上皮屏障功能的基因中75%在验证中呈一致性上调;hsa-miR-125b-5p靶向CGN,hsa-miR-16靶向CLDN2。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Micro-RNAs (miRNAs) play a crucial role in controlling intestinal epithelial barrier function partly by modulating the expression of tight junction (TJ) proteins. We have previously shown differential messenger RNA (mRNA) expression correlated with ultrastructural abnormalities of the epithelial barrier in patients with diarrhoea-predominant IBS (IBS-D). However, the participation of miRNAs in these differential mRNA-associated findings remains to be established. Our aims were (1) to identify miRNAs differentially expressed in the small bowel mucosa of patients with IBS-D and (2) to explore putative target genes specifically involved in epithelial barrier function that are controlled by specific dysregulated IBS-D miRNAs. DESIGN: Healthy controls and patients meeting Rome III IBS-D criteria were studied. Intestinal tissue samples were analysed to identify potential candidates by: (a) miRNA-mRNA profiling; (b) miRNA-mRNA pairing analysis to assess the co-expression profile of miRNA-mRNA pairs; (c) pathway analysis and upstream regulator identification; (d) miRNA and target mRNA validation. Candidate miRNA-mRNA pairs were functionally assessed in intestinal epithelial cells. RESULTS: IBS-D samples showed distinct miRNA and mRNA profiles compared with healthy controls. TJ signalling was associated with the IBS-D transcriptional profile. Further validation of selected genes showed consistent upregulation in 75% of genes involved in epithelial barrier function. Bioinformatic analysis of putative miRNA binding sites identified hsa-miR-125b-5p and hsa-miR-16 as regulating expression of the TJ genes CGN (cingulin) and CLDN2 (claudin-2), respectively. Consistently, protein expression of CGN and CLDN2 was upregulated in IBS-D, while the respective targeting miRNAs were downregulated. In addition, bowel dysfunction, perceived stress and depression and number of mast cells correlated with the expression of hsa-miR-125b-5p and hsa-miR-16 and their respective target proteins. CONCLUSIONS: Modulation of the intestinal epithelial barrier function in IBS-D involves both transcriptional and post-transcriptional mechanisms. These molecular mechanisms include miRNAs as master regulators in controlling the expression of TJ proteins and are associated with major clinical symptoms.
引用
- Martínez C, Rodiño-Janeiro BK, Lobo B, et al. miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea. Gut. 2017. PMID: 28082316. doi:10.1136/gutjnl-2016-311477
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。